| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mouth Neoplasms | 23 | 2024 | 593 | 5.990 |
Why?
|
| Leukoplakia, Oral | 16 | 2024 | 77 | 5.950 |
Why?
|
| Mouth Diseases | 21 | 2024 | 238 | 5.480 |
Why?
|
| Mouth Mucosa | 23 | 2024 | 426 | 4.080 |
Why?
|
| Osteonecrosis | 21 | 2022 | 229 | 4.050 |
Why?
|
| Lichen Planus, Oral | 12 | 2023 | 56 | 3.530 |
Why?
|
| Keratosis | 7 | 2021 | 80 | 3.320 |
Why?
|
| Jaw Diseases | 14 | 2020 | 92 | 3.310 |
Why?
|
| Diphosphonates | 19 | 2016 | 638 | 3.170 |
Why?
|
| Odontogenic Tumors | 7 | 2021 | 45 | 2.640 |
Why?
|
| Precancerous Conditions | 11 | 2024 | 978 | 2.460 |
Why?
|
| Oral Ulcer | 12 | 2021 | 96 | 2.310 |
Why?
|
| Mandibular Diseases | 10 | 2016 | 119 | 2.270 |
Why?
|
| Tongue | 6 | 2022 | 404 | 1.970 |
Why?
|
| Gingival Diseases | 4 | 2023 | 36 | 1.920 |
Why?
|
| Mouth | 6 | 2020 | 380 | 1.820 |
Why?
|
| Bone Density Conservation Agents | 12 | 2011 | 794 | 1.670 |
Why?
|
| Tongue Diseases | 5 | 2021 | 68 | 1.610 |
Why?
|
| Carcinoma, Squamous Cell | 14 | 2024 | 4024 | 1.150 |
Why?
|
| Palate, Hard | 5 | 2017 | 58 | 1.040 |
Why?
|
| Tongue Neoplasms | 5 | 2022 | 183 | 1.040 |
Why?
|
| Diagnosis, Differential | 38 | 2023 | 12968 | 1.020 |
Why?
|
| Epstein-Barr Virus Infections | 4 | 2021 | 608 | 1.000 |
Why?
|
| Jaw | 5 | 2017 | 93 | 0.980 |
Why?
|
| Alveolar Process | 3 | 2020 | 294 | 0.970 |
Why?
|
| Palatal Neoplasms | 4 | 2017 | 37 | 0.900 |
Why?
|
| Stomatitis | 4 | 2021 | 271 | 0.890 |
Why?
|
| Graft vs Host Disease | 15 | 2018 | 3023 | 0.870 |
Why?
|
| Foreign-Body Reaction | 2 | 2014 | 158 | 0.860 |
Why?
|
| Mandibular Neoplasms | 3 | 2020 | 130 | 0.840 |
Why?
|
| Papillomavirus Infections | 4 | 2017 | 1600 | 0.840 |
Why?
|
| Carcinoma in Situ | 3 | 2021 | 796 | 0.820 |
Why?
|
| CREST Syndrome | 1 | 2022 | 6 | 0.810 |
Why?
|
| Leukemia, Eosinophilic, Acute | 1 | 2021 | 5 | 0.800 |
Why?
|
| Burning Mouth Syndrome | 4 | 2019 | 25 | 0.770 |
Why?
|
| Bronchogenic Cyst | 1 | 2021 | 28 | 0.760 |
Why?
|
| Erythema | 2 | 2023 | 262 | 0.750 |
Why?
|
| Salivary Gland Diseases | 2 | 2019 | 37 | 0.740 |
Why?
|
| Lichenoid Eruptions | 1 | 2020 | 13 | 0.740 |
Why?
|
| Herpes Labialis | 3 | 2010 | 28 | 0.720 |
Why?
|
| Jaw Neoplasms | 3 | 2015 | 70 | 0.710 |
Why?
|
| Diagnosis, Oral | 2 | 2014 | 23 | 0.710 |
Why?
|
| Maxillary Neoplasms | 2 | 2020 | 47 | 0.690 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2019 | 66 | 0.690 |
Why?
|
| Sarcoma, Synovial | 1 | 2020 | 151 | 0.650 |
Why?
|
| Triamcinolone Acetonide | 3 | 2019 | 100 | 0.650 |
Why?
|
| Immunosuppressive Agents | 6 | 2018 | 4168 | 0.640 |
Why?
|
| Humans | 191 | 2024 | 760261 | 0.620 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 2 | 2019 | 115 | 0.620 |
Why?
|
| Middle Aged | 94 | 2024 | 220175 | 0.620 |
Why?
|
| Candidiasis, Oral | 2 | 2016 | 57 | 0.620 |
Why?
|
| Female | 120 | 2024 | 391011 | 0.620 |
Why?
|
| Lip Neoplasms | 2 | 2011 | 36 | 0.610 |
Why?
|
| Jaw Cysts | 2 | 2015 | 8 | 0.600 |
Why?
|
| Lymphocytes | 2 | 2024 | 2612 | 0.600 |
Why?
|
| Male | 110 | 2024 | 359413 | 0.600 |
Why?
|
| Pigmentation Disorders | 2 | 2023 | 105 | 0.590 |
Why?
|
| Aged | 78 | 2024 | 168995 | 0.590 |
Why?
|
| Hyperplasia | 5 | 2022 | 1158 | 0.580 |
Why?
|
| Lipoma | 2 | 2018 | 292 | 0.580 |
Why?
|
| Aged, 80 and over | 41 | 2024 | 58947 | 0.580 |
Why?
|
| Salivary Ducts | 1 | 2017 | 25 | 0.580 |
Why?
|
| Leukoplakia | 3 | 2020 | 18 | 0.570 |
Why?
|
| Xerostomia | 3 | 2020 | 94 | 0.570 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 12 | 2018 | 5644 | 0.550 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2013 | 533 | 0.530 |
Why?
|
| Pemphigoid, Bullous | 2 | 2019 | 114 | 0.530 |
Why?
|
| Biopsy | 11 | 2021 | 6775 | 0.520 |
Why?
|
| Leukoplakia, Hairy | 3 | 2021 | 9 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 368 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2022 | 2823 | 0.510 |
Why?
|
| Dental Care | 2 | 2019 | 278 | 0.500 |
Why?
|
| Gingivitis | 3 | 2019 | 124 | 0.490 |
Why?
|
| Adult | 70 | 2024 | 219847 | 0.480 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 556 | 0.470 |
Why?
|
| Imidazoles | 4 | 2016 | 1178 | 0.450 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2015 | 241 | 0.440 |
Why?
|
| Sialometaplasia, Necrotizing | 2 | 2012 | 6 | 0.440 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2013 | 76 | 0.440 |
Why?
|
| Neurofibroma | 1 | 2013 | 94 | 0.430 |
Why?
|
| Oral Medicine | 3 | 2023 | 31 | 0.420 |
Why?
|
| Sublingual Gland Neoplasms | 1 | 2012 | 2 | 0.420 |
Why?
|
| Granulomatosis, Orofacial | 1 | 2012 | 2 | 0.420 |
Why?
|
| Epistaxis | 1 | 2013 | 111 | 0.420 |
Why?
|
| Immunocompromised Host | 2 | 2016 | 857 | 0.420 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2013 | 70 | 0.410 |
Why?
|
| Glucocorticoids | 5 | 2019 | 2143 | 0.410 |
Why?
|
| Carrier State | 1 | 2016 | 525 | 0.410 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 367 | 0.410 |
Why?
|
| Durapatite | 1 | 2013 | 163 | 0.410 |
Why?
|
| Skull Base Neoplasms | 1 | 2015 | 269 | 0.400 |
Why?
|
| Craniofacial Abnormalities | 2 | 2014 | 315 | 0.400 |
Why?
|
| Bronchiectasis | 1 | 2013 | 138 | 0.400 |
Why?
|
| Intubation | 1 | 2012 | 139 | 0.390 |
Why?
|
| Granuloma | 2 | 2024 | 328 | 0.390 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 13629 | 0.390 |
Why?
|
| Absorbable Implants | 1 | 2014 | 345 | 0.390 |
Why?
|
| Foreign-Body Migration | 1 | 2013 | 218 | 0.390 |
Why?
|
| Cysts | 1 | 2017 | 683 | 0.390 |
Why?
|
| Fibroma | 2 | 2017 | 190 | 0.380 |
Why?
|
| Bone Marrow | 1 | 2021 | 2918 | 0.380 |
Why?
|
| Xanthomatosis | 1 | 2011 | 32 | 0.380 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2013 | 167 | 0.370 |
Why?
|
| Mouth Rehabilitation | 1 | 2010 | 10 | 0.370 |
Why?
|
| Salivary Glands, Minor | 2 | 2013 | 25 | 0.370 |
Why?
|
| Hyperpigmentation | 2 | 2020 | 117 | 0.370 |
Why?
|
| Bacteremia | 2 | 2017 | 979 | 0.370 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 441 | 0.360 |
Why?
|
| Dental Caries | 3 | 2012 | 420 | 0.360 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 218 | 0.360 |
Why?
|
| Tumor Virus Infections | 1 | 2013 | 438 | 0.360 |
Why?
|
| Tooth Abnormalities | 1 | 2010 | 56 | 0.360 |
Why?
|
| Fatty Alcohols | 1 | 2010 | 22 | 0.360 |
Why?
|
| Papillomaviridae | 2 | 2014 | 1117 | 0.360 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 319 | 0.350 |
Why?
|
| Biological Factors | 3 | 2022 | 158 | 0.350 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2014 | 385 | 0.350 |
Why?
|
| Transplantation Conditioning | 3 | 2017 | 1593 | 0.350 |
Why?
|
| Maxillary Diseases | 2 | 2010 | 48 | 0.350 |
Why?
|
| Melanosis | 2 | 2008 | 93 | 0.340 |
Why?
|
| Nose | 1 | 2013 | 519 | 0.340 |
Why?
|
| Dental Fistula | 1 | 2009 | 12 | 0.340 |
Why?
|
| Dwarfism | 1 | 2010 | 137 | 0.340 |
Why?
|
| Retrospective Studies | 38 | 2024 | 80301 | 0.330 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 2250 | 0.330 |
Why?
|
| Automatism | 1 | 2009 | 10 | 0.330 |
Why?
|
| Radiography, Panoramic | 3 | 2015 | 118 | 0.330 |
Why?
|
| Coagulation Protein Disorders | 1 | 2008 | 6 | 0.330 |
Why?
|
| Streptococcal Infections | 1 | 2014 | 617 | 0.330 |
Why?
|
| Granular Cell Tumor | 2 | 2014 | 48 | 0.330 |
Why?
|
| Lip Diseases | 2 | 2012 | 18 | 0.330 |
Why?
|
| Quinacrine | 1 | 2008 | 24 | 0.320 |
Why?
|
| Stomatitis, Aphthous | 2 | 2024 | 52 | 0.320 |
Why?
|
| Adolescent | 33 | 2023 | 87747 | 0.320 |
Why?
|
| Collagen | 2 | 2014 | 2635 | 0.320 |
Why?
|
| Plasminogen | 1 | 2008 | 146 | 0.310 |
Why?
|
| Mouthwashes | 4 | 2021 | 57 | 0.310 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2009 | 67 | 0.310 |
Why?
|
| Lactic Acid | 1 | 2013 | 1132 | 0.310 |
Why?
|
| Neurodermatitis | 1 | 2008 | 8 | 0.310 |
Why?
|
| Republic of Korea | 10 | 2024 | 567 | 0.310 |
Why?
|
| Hyaluronic Acid | 1 | 2011 | 482 | 0.300 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2008 | 61 | 0.300 |
Why?
|
| Paresthesia | 2 | 2020 | 162 | 0.300 |
Why?
|
| Dexamethasone | 3 | 2024 | 1928 | 0.290 |
Why?
|
| Keratinocytes | 4 | 2021 | 792 | 0.290 |
Why?
|
| Administration, Topical | 5 | 2018 | 697 | 0.290 |
Why?
|
| Clonazepam | 2 | 2017 | 133 | 0.280 |
Why?
|
| Bone Neoplasms | 3 | 2015 | 2532 | 0.280 |
Why?
|
| Antiviral Agents | 4 | 2014 | 3061 | 0.280 |
Why?
|
| Young Adult | 25 | 2024 | 58673 | 0.280 |
Why?
|
| Odontogenic Cysts | 2 | 2020 | 42 | 0.280 |
Why?
|
| Polymers | 1 | 2013 | 1620 | 0.270 |
Why?
|
| Heart Valves | 1 | 2008 | 285 | 0.270 |
Why?
|
| Acyclovir | 1 | 2007 | 269 | 0.270 |
Why?
|
| Polyps | 1 | 2007 | 197 | 0.260 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2010 | 470 | 0.260 |
Why?
|
| Salivary Glands | 3 | 2019 | 229 | 0.250 |
Why?
|
| Valine | 1 | 2007 | 409 | 0.250 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 1689 | 0.250 |
Why?
|
| Pain Measurement | 3 | 2012 | 3514 | 0.250 |
Why?
|
| Herpesvirus 4, Human | 4 | 2021 | 1075 | 0.250 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2005 | 75 | 0.240 |
Why?
|
| Periodontal Diseases | 1 | 2008 | 452 | 0.230 |
Why?
|
| Dyskeratosis Congenita | 1 | 2004 | 73 | 0.230 |
Why?
|
| Parotid Neoplasms | 1 | 2005 | 157 | 0.230 |
Why?
|
| Endocarditis, Bacterial | 1 | 2008 | 445 | 0.220 |
Why?
|
| Osteoradionecrosis | 2 | 2017 | 51 | 0.220 |
Why?
|
| Minocycline | 1 | 2004 | 168 | 0.210 |
Why?
|
| Adenoma | 2 | 2011 | 2148 | 0.210 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2730 | 0.200 |
Why?
|
| Gingival Neoplasms | 2 | 2019 | 20 | 0.200 |
Why?
|
| Hydrazines | 1 | 2024 | 224 | 0.200 |
Why?
|
| Radiography | 10 | 2018 | 6965 | 0.200 |
Why?
|
| Stomatitis, Herpetic | 2 | 2014 | 12 | 0.190 |
Why?
|
| Prednisone | 4 | 2014 | 1566 | 0.190 |
Why?
|
| Tooth, Impacted | 2 | 2015 | 43 | 0.190 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2005 | 304 | 0.190 |
Why?
|
| Antimalarials | 1 | 2008 | 907 | 0.190 |
Why?
|
| Prevalence | 12 | 2017 | 15687 | 0.190 |
Why?
|
| Chewing Gum | 1 | 2021 | 40 | 0.190 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 693 | 0.190 |
Why?
|
| Pathology, Oral | 1 | 2021 | 5 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2013 | 698 | 0.190 |
Why?
|
| Piperazines | 1 | 2011 | 2520 | 0.190 |
Why?
|
| Mandible | 2 | 2021 | 749 | 0.190 |
Why?
|
| Immunohistochemistry | 8 | 2018 | 11064 | 0.190 |
Why?
|
| Sarcoma, Myeloid | 1 | 2021 | 51 | 0.180 |
Why?
|
| Periapical Diseases | 2 | 2012 | 21 | 0.180 |
Why?
|
| Health Care Costs | 1 | 2014 | 3257 | 0.180 |
Why?
|
| Anti-Ulcer Agents | 1 | 2021 | 113 | 0.180 |
Why?
|
| Lymphocytosis | 1 | 2021 | 119 | 0.180 |
Why?
|
| Child | 19 | 2024 | 79758 | 0.180 |
Why?
|
| Tooth Extraction | 3 | 2011 | 229 | 0.170 |
Why?
|
| Tobacco, Smokeless | 1 | 2021 | 133 | 0.170 |
Why?
|
| Warfarin | 1 | 2008 | 1516 | 0.170 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2020 | 85 | 0.170 |
Why?
|
| Hydroxychloroquine | 1 | 2023 | 428 | 0.170 |
Why?
|
| Pyrimidines | 1 | 2011 | 3011 | 0.170 |
Why?
|
| Pain | 3 | 2023 | 5066 | 0.160 |
Why?
|
| Heart Valve Prosthesis | 1 | 2008 | 1494 | 0.160 |
Why?
|
| Hearing Loss | 2 | 2017 | 780 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 2469 | 0.160 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 749 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 2880 | 0.160 |
Why?
|
| Adipocytes | 1 | 2005 | 1179 | 0.160 |
Why?
|
| False Negative Reactions | 1 | 2019 | 574 | 0.160 |
Why?
|
| Algorithms | 2 | 2016 | 13967 | 0.160 |
Why?
|
| Triazoles | 1 | 2024 | 904 | 0.150 |
Why?
|
| Pemphigus | 1 | 2019 | 116 | 0.150 |
Why?
|
| Lung | 2 | 2013 | 9989 | 0.150 |
Why?
|
| Otoscopy | 1 | 2017 | 40 | 0.150 |
Why?
|
| Severity of Illness Index | 6 | 2013 | 15827 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 1799 | 0.140 |
Why?
|
| Sjogren's Syndrome | 1 | 2019 | 235 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2008 | 1583 | 0.140 |
Why?
|
| Follow-Up Studies | 13 | 2024 | 39254 | 0.140 |
Why?
|
| Gingival Hyperplasia | 2 | 2015 | 19 | 0.140 |
Why?
|
| Injections, Intralesional | 2 | 2019 | 278 | 0.140 |
Why?
|
| Eosinophilia | 1 | 2021 | 560 | 0.140 |
Why?
|
| Atrophy | 1 | 2022 | 1625 | 0.140 |
Why?
|
| 5-Methylcytosine | 1 | 2017 | 146 | 0.140 |
Why?
|
| Tacrolimus | 2 | 2018 | 730 | 0.140 |
Why?
|
| Alendronate | 2 | 2010 | 174 | 0.140 |
Why?
|
| Necrosis | 1 | 2021 | 1612 | 0.140 |
Why?
|
| Antigens, CD | 2 | 2018 | 4002 | 0.140 |
Why?
|
| Epithelium | 1 | 2021 | 1605 | 0.140 |
Why?
|
| Otitis Media, Suppurative | 1 | 2016 | 27 | 0.140 |
Why?
|
| Treatment Outcome | 17 | 2024 | 64947 | 0.140 |
Why?
|
| Cementoma | 1 | 2015 | 6 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2058 | 0.130 |
Why?
|
| Semaphorins | 1 | 2016 | 97 | 0.130 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 1745 | 0.130 |
Why?
|
| Injections, Intravenous | 2 | 2008 | 1388 | 0.130 |
Why?
|
| Sodium Tetradecyl Sulfate | 1 | 2015 | 14 | 0.130 |
Why?
|
| Dental Cementum | 1 | 2015 | 53 | 0.130 |
Why?
|
| Amyloid | 2 | 2024 | 843 | 0.130 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 4109 | 0.130 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2017 | 166 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2024 | 1252 | 0.130 |
Why?
|
| Odontogenesis | 1 | 2015 | 65 | 0.130 |
Why?
|
| Ossicular Replacement | 1 | 2015 | 11 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 643 | 0.130 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 12156 | 0.130 |
Why?
|
| Multiple Myeloma | 4 | 2024 | 5131 | 0.130 |
Why?
|
| Periodontium | 1 | 2015 | 97 | 0.130 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2015 | 52 | 0.130 |
Why?
|
| Neck Dissection | 1 | 2017 | 201 | 0.130 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 266 | 0.130 |
Why?
|
| Liposarcoma | 1 | 2018 | 283 | 0.130 |
Why?
|
| Bone Matrix | 1 | 2015 | 118 | 0.130 |
Why?
|
| Postoperative Complications | 3 | 2014 | 15680 | 0.130 |
Why?
|
| Oral Health | 2 | 2019 | 484 | 0.120 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2015 | 25 | 0.120 |
Why?
|
| Risk Factors | 19 | 2021 | 74269 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 1765 | 0.120 |
Why?
|
| Fibroma, Ossifying | 1 | 2015 | 14 | 0.120 |
Why?
|
| Tympanoplasty | 1 | 2015 | 71 | 0.120 |
Why?
|
| Edema | 1 | 2019 | 772 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2013 | 1870 | 0.120 |
Why?
|
| Drug Compounding | 1 | 2016 | 245 | 0.120 |
Why?
|
| Ear | 1 | 2015 | 172 | 0.120 |
Why?
|
| Dementia, Vascular | 1 | 2015 | 125 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 2500 | 0.120 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1401 | 0.120 |
Why?
|
| Hearing Loss, Conductive | 1 | 2015 | 159 | 0.120 |
Why?
|
| Collateral Circulation | 1 | 2015 | 292 | 0.120 |
Why?
|
| Sclerotherapy | 1 | 2015 | 181 | 0.120 |
Why?
|
| Cheilitis | 1 | 2013 | 7 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2015 | 4091 | 0.120 |
Why?
|
| Ear, External | 1 | 2014 | 164 | 0.110 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2014 | 28 | 0.110 |
Why?
|
| Child, Preschool | 10 | 2024 | 42034 | 0.110 |
Why?
|
| Neoplasms | 6 | 2021 | 22066 | 0.110 |
Why?
|
| Injections, Intradermal | 1 | 2013 | 116 | 0.110 |
Why?
|
| Osteotomy, Le Fort | 1 | 2014 | 93 | 0.110 |
Why?
|
| Mycobacterium avium Complex | 1 | 2013 | 59 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3826 | 0.110 |
Why?
|
| Maxilla | 1 | 2016 | 490 | 0.110 |
Why?
|
| Ethambutol | 1 | 2013 | 59 | 0.110 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2014 | 192 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2020 | 1511 | 0.110 |
Why?
|
| Hearing | 1 | 2017 | 501 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2024 | 11708 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 3606 | 0.110 |
Why?
|
| Clarithromycin | 1 | 2013 | 85 | 0.110 |
Why?
|
| Ear Diseases | 1 | 2014 | 177 | 0.110 |
Why?
|
| Furcation Defects | 1 | 2013 | 37 | 0.110 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 229 | 0.110 |
Why?
|
| Chest Wall Oscillation | 1 | 2012 | 15 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2008 | 4896 | 0.110 |
Why?
|
| Dizziness | 1 | 2015 | 256 | 0.110 |
Why?
|
| Genomics | 2 | 2019 | 5790 | 0.100 |
Why?
|
| Sex Factors | 4 | 2017 | 10530 | 0.100 |
Why?
|
| Lung Volume Measurements | 1 | 2013 | 376 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 7400 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 1591 | 0.100 |
Why?
|
| Oncology Service, Hospital | 1 | 2012 | 58 | 0.100 |
Why?
|
| Refugees | 1 | 2020 | 598 | 0.100 |
Why?
|
| Osteomyelitis | 1 | 2016 | 407 | 0.100 |
Why?
|
| Thymus Neoplasms | 1 | 2014 | 274 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3618 | 0.100 |
Why?
|
| Azithromycin | 1 | 2013 | 201 | 0.100 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 2852 | 0.100 |
Why?
|
| Chronic Disease | 7 | 2016 | 9283 | 0.100 |
Why?
|
| Viscosupplements | 1 | 2011 | 21 | 0.100 |
Why?
|
| Boston | 4 | 2019 | 9282 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 20484 | 0.100 |
Why?
|
| Polyesters | 1 | 2013 | 372 | 0.100 |
Why?
|
| Myxoma | 1 | 2012 | 114 | 0.100 |
Why?
|
| Tinnitus | 1 | 2014 | 194 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 2 | 2008 | 831 | 0.100 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 412 | 0.100 |
Why?
|
| Rifampin | 1 | 2013 | 341 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3335 | 0.090 |
Why?
|
| Gingiva | 1 | 2013 | 406 | 0.090 |
Why?
|
| Foam Cells | 1 | 2011 | 68 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 538 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2024 | 4637 | 0.090 |
Why?
|
| Oroantral Fistula | 1 | 2010 | 8 | 0.090 |
Why?
|
| Dry Socket | 1 | 2010 | 7 | 0.090 |
Why?
|
| Radiography, Dental, Digital | 1 | 2010 | 13 | 0.090 |
Why?
|
| Root Resorption | 1 | 2010 | 44 | 0.090 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2011 | 125 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 487 | 0.090 |
Why?
|
| Rhinoplasty | 1 | 2014 | 238 | 0.090 |
Why?
|
| Menisci, Tibial | 1 | 2013 | 269 | 0.090 |
Why?
|
| Micrognathism | 1 | 2010 | 63 | 0.090 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 704 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2014 | 453 | 0.090 |
Why?
|
| Lip | 1 | 2012 | 197 | 0.090 |
Why?
|
| Osteosclerosis | 1 | 2010 | 42 | 0.090 |
Why?
|
| Dementia | 1 | 2024 | 2638 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 6310 | 0.090 |
Why?
|
| Lidocaine | 1 | 2013 | 538 | 0.090 |
Why?
|
| Vascular Malformations | 1 | 2015 | 464 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 1361 | 0.090 |
Why?
|
| Facies | 1 | 2010 | 223 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2011 | 555 | 0.080 |
Why?
|
| Amyloidosis | 1 | 2016 | 818 | 0.080 |
Why?
|
| Cosmetic Techniques | 1 | 2011 | 148 | 0.080 |
Why?
|
| Dentists | 2 | 2022 | 174 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 2927 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2978 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2019 | 1374 | 0.080 |
Why?
|
| Bites, Human | 1 | 2009 | 10 | 0.080 |
Why?
|
| Immunologic Factors | 2 | 2021 | 1589 | 0.080 |
Why?
|
| Uterine Cervicitis | 1 | 2008 | 31 | 0.080 |
Why?
|
| Vasculitis | 1 | 2013 | 523 | 0.080 |
Why?
|
| Friction | 1 | 2009 | 59 | 0.080 |
Why?
|
| Health Surveys | 2 | 2016 | 4061 | 0.080 |
Why?
|
| Nonprescription Drugs | 1 | 2010 | 118 | 0.080 |
Why?
|
| Tooth Socket | 1 | 2010 | 131 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2627 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2015 | 1897 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2016 | 1612 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2020 | 9274 | 0.080 |
Why?
|
| Periodontal Pocket | 1 | 2009 | 167 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 791 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2002 | 3217 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 4044 | 0.080 |
Why?
|
| Survival Rate | 6 | 2024 | 12806 | 0.080 |
Why?
|
| Dental Care for Chronically Ill | 1 | 2008 | 32 | 0.080 |
Why?
|
| Habits | 1 | 2009 | 146 | 0.080 |
Why?
|
| Saliva | 2 | 2019 | 816 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4554 | 0.070 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2008 | 49 | 0.070 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2008 | 89 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 3839 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2015 | 1054 | 0.070 |
Why?
|
| Prognosis | 7 | 2020 | 29636 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 2 | 2017 | 1705 | 0.070 |
Why?
|
| Trachea | 1 | 2013 | 1082 | 0.070 |
Why?
|
| Age Distribution | 2 | 2014 | 2893 | 0.070 |
Why?
|
| Sirolimus | 1 | 2014 | 1548 | 0.070 |
Why?
|
| Korea | 3 | 2012 | 96 | 0.070 |
Why?
|
| Trigeminal Ganglion | 1 | 2008 | 190 | 0.070 |
Why?
|
| Survivors | 1 | 2018 | 2367 | 0.070 |
Why?
|
| Erythema Multiforme | 1 | 2007 | 31 | 0.070 |
Why?
|
| Observer Variation | 3 | 2013 | 2596 | 0.070 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 1462 | 0.070 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 652 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 685 | 0.070 |
Why?
|
| Syndrome | 2 | 2010 | 3278 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 2 | 2005 | 2696 | 0.070 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 927 | 0.070 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 1094 | 0.070 |
Why?
|
| Bell Palsy | 1 | 2007 | 39 | 0.070 |
Why?
|
| Drinking | 1 | 2008 | 199 | 0.070 |
Why?
|
| Prospective Studies | 8 | 2019 | 54263 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2866 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 11141 | 0.070 |
Why?
|
| Recurrence | 3 | 2021 | 8487 | 0.070 |
Why?
|
| Clindamycin | 1 | 2006 | 140 | 0.070 |
Why?
|
| Inflammation | 3 | 2015 | 10757 | 0.070 |
Why?
|
| Phenotype | 2 | 2021 | 16543 | 0.070 |
Why?
|
| Sunscreening Agents | 1 | 2007 | 139 | 0.070 |
Why?
|
| Societies, Dental | 1 | 2005 | 33 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1882 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1840 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2013 | 1001 | 0.070 |
Why?
|
| Benzamides | 1 | 2011 | 1369 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2012 | 898 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3466 | 0.060 |
Why?
|
| Cytosine | 1 | 2007 | 212 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2019 | 41317 | 0.060 |
Why?
|
| Photography, Dental | 1 | 2005 | 22 | 0.060 |
Why?
|
| Mesenchymoma | 1 | 2005 | 49 | 0.060 |
Why?
|
| Pneumonectomy | 1 | 2012 | 1110 | 0.060 |
Why?
|
| Xerophthalmia | 1 | 2005 | 12 | 0.060 |
Why?
|
| Secretory Rate | 1 | 2005 | 81 | 0.060 |
Why?
|
| Chlorhexidine | 1 | 2006 | 160 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2014 | 1606 | 0.060 |
Why?
|
| Apolipoproteins E | 2 | 2024 | 1437 | 0.060 |
Why?
|
| Shock, Septic | 1 | 2012 | 760 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 1423 | 0.060 |
Why?
|
| Technology Transfer | 1 | 2005 | 42 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 2660 | 0.060 |
Why?
|
| Incidence | 4 | 2016 | 21378 | 0.060 |
Why?
|
| Age Factors | 3 | 2017 | 18415 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2014 | 12532 | 0.060 |
Why?
|
| Metaplasia | 1 | 2005 | 320 | 0.060 |
Why?
|
| Laryngoscopy | 1 | 2010 | 706 | 0.060 |
Why?
|
| Quality of Life | 7 | 2020 | 13300 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2014 | 1915 | 0.060 |
Why?
|
| Noise | 2 | 2017 | 280 | 0.060 |
Why?
|
| Wound Healing | 3 | 2011 | 2786 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3215 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 1378 | 0.060 |
Why?
|
| Congresses as Topic | 2 | 2019 | 804 | 0.060 |
Why?
|
| Comorbidity | 3 | 2017 | 10552 | 0.060 |
Why?
|
| Homozygote | 1 | 2008 | 1786 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2334 | 0.060 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8551 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2783 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 1790 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 5755 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6499 | 0.050 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2005 | 226 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2008 | 1821 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2015 | 3728 | 0.050 |
Why?
|
| Drug Approval | 1 | 2010 | 816 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2007 | 1833 | 0.050 |
Why?
|
| S100 Proteins | 1 | 2003 | 218 | 0.050 |
Why?
|
| Anemia, Aplastic | 1 | 2004 | 228 | 0.050 |
Why?
|
| Abdominal Neoplasms | 1 | 2024 | 286 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2015 | 3604 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2005 | 250 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2014 | 2155 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 10183 | 0.050 |
Why?
|
| Muromonab-CD3 | 1 | 2002 | 104 | 0.050 |
Why?
|
| Self-Injurious Behavior | 1 | 2009 | 559 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1408 | 0.050 |
Why?
|
| Patient Care Planning | 1 | 2008 | 909 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15273 | 0.050 |
Why?
|
| Cranial Irradiation | 1 | 2005 | 391 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3390 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 1328 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 10340 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2275 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2013 | 2877 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2020 | 25928 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6545 | 0.050 |
Why?
|
| Animals | 8 | 2020 | 167940 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 1866 | 0.050 |
Why?
|
| Withholding Treatment | 1 | 2006 | 613 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3598 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2010 | 1675 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2015 | 3976 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2008 | 935 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2012 | 5420 | 0.050 |
Why?
|
| Democratic People's Republic of Korea | 1 | 2020 | 12 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3613 | 0.050 |
Why?
|
| Steroids | 1 | 2006 | 928 | 0.050 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2024 | 329 | 0.050 |
Why?
|
| Massachusetts | 1 | 2014 | 8805 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2017 | 1181 | 0.050 |
Why?
|
| Mucocele | 2 | 2012 | 51 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2007 | 1548 | 0.040 |
Why?
|
| Logistic Models | 4 | 2017 | 13311 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2012 | 2321 | 0.040 |
Why?
|
| Mastectomy | 1 | 2008 | 1834 | 0.040 |
Why?
|
| Disease Progression | 2 | 2016 | 13505 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2005 | 708 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 2008 | 1047 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2006 | 1617 | 0.040 |
Why?
|
| Professional Role | 1 | 2022 | 311 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2024 | 597 | 0.040 |
Why?
|
| Time Factors | 6 | 2014 | 40133 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2023 | 824 | 0.040 |
Why?
|
| Community Medicine | 1 | 2019 | 23 | 0.040 |
Why?
|
| Critical Illness | 1 | 2012 | 2709 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 982 | 0.040 |
Why?
|
| Brain | 2 | 2016 | 26912 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 591 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2019 | 8553 | 0.040 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2002 | 270 | 0.040 |
Why?
|
| Lasers | 1 | 2023 | 952 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3737 | 0.040 |
Why?
|
| Nutrition Surveys | 2 | 2017 | 1727 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3223 | 0.040 |
Why?
|
| Thalidomide | 1 | 2024 | 884 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 20048 | 0.040 |
Why?
|
| Mutation | 2 | 2020 | 29950 | 0.040 |
Why?
|
| Loneliness | 1 | 2020 | 196 | 0.040 |
Why?
|
| Lung Transplantation | 1 | 2007 | 1304 | 0.040 |
Why?
|
| Personal Autonomy | 1 | 2020 | 302 | 0.040 |
Why?
|
| Body Height | 1 | 2024 | 1570 | 0.040 |
Why?
|
| United States | 4 | 2015 | 72363 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2014 | 6830 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9388 | 0.040 |
Why?
|
| Positron-Emission Tomography | 3 | 2024 | 6457 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2056 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1602 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2023 | 1972 | 0.040 |
Why?
|
| ROC Curve | 2 | 2015 | 3568 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 36247 | 0.030 |
Why?
|
| Audiometry | 1 | 2017 | 253 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2007 | 2560 | 0.030 |
Why?
|
| Solutions | 1 | 2017 | 423 | 0.030 |
Why?
|
| Aging | 1 | 2015 | 8641 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1434 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2005 | 1600 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2008 | 3185 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 2003 | 0.030 |
Why?
|
| Cognition | 2 | 2024 | 6948 | 0.030 |
Why?
|
| Sclerosing Solutions | 1 | 2015 | 79 | 0.030 |
Why?
|
| Odontogenic Cyst, Calcifying | 1 | 2015 | 6 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2007 | 3903 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2013 | 2363 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2016 | 9196 | 0.030 |
Why?
|
| Nevus | 1 | 2016 | 205 | 0.030 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2014 | 50 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2015 | 210 | 0.030 |
Why?
|
| Hearing Tests | 1 | 2015 | 121 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2024 | 1867 | 0.030 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2014 | 45 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2016 | 345 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2019 | 746 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2016 | 4044 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2014 | 4814 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 5797 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2017 | 657 | 0.030 |
Why?
|
| Petrolatum | 1 | 2013 | 7 | 0.030 |
Why?
|
| Photomicrography | 1 | 2013 | 71 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 21065 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3302 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2018 | 547 | 0.030 |
Why?
|
| Keratolytic Agents | 1 | 2013 | 34 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 1649 | 0.030 |
Why?
|
| Emollients | 1 | 2013 | 41 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5248 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10761 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10185 | 0.030 |
Why?
|
| Mupirocin | 1 | 2013 | 55 | 0.030 |
Why?
|
| Auditory Threshold | 1 | 2015 | 369 | 0.030 |
Why?
|
| Otitis Media with Effusion | 1 | 2014 | 114 | 0.030 |
Why?
|
| Periodontal Cyst | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15740 | 0.030 |
Why?
|
| Acute Disease | 2 | 2014 | 7268 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3106 | 0.030 |
Why?
|
| Keloid | 1 | 2013 | 54 | 0.030 |
Why?
|
| Endoscopy | 1 | 2023 | 1841 | 0.030 |
Why?
|
| Stroke | 1 | 2015 | 9945 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2012 | 75 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 4215 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 412 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2017 | 9712 | 0.030 |
Why?
|
| Color | 1 | 2013 | 298 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 3618 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1999 | 0.030 |
Why?
|
| Nomograms | 1 | 2014 | 238 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14656 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 1266 | 0.030 |
Why?
|
| Keratins | 1 | 2013 | 497 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 631 | 0.020 |
Why?
|
| Respiratory Therapy | 1 | 2012 | 127 | 0.020 |
Why?
|
| Memory | 1 | 2021 | 2179 | 0.020 |
Why?
|
| Esthetics, Dental | 1 | 2013 | 268 | 0.020 |
Why?
|
| Vincristine | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2016 | 1518 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1635 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2016 | 1068 | 0.020 |
Why?
|
| Postural Balance | 1 | 2015 | 617 | 0.020 |
Why?
|
| Tretinoin | 1 | 2013 | 519 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2012 | 378 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 725 | 0.020 |
Why?
|
| Infant | 3 | 2024 | 36030 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 530 | 0.020 |
Why?
|
| Educational Status | 1 | 2017 | 2512 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 14482 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2013 | 306 | 0.020 |
Why?
|
| Chest Tubes | 1 | 2010 | 151 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2295 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2014 | 1122 | 0.020 |
Why?
|
| Herpes Simplex | 1 | 2013 | 477 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2019 | 12901 | 0.020 |
Why?
|
| Thiazoles | 1 | 2016 | 1509 | 0.020 |
Why?
|
| Anthropometry | 1 | 2014 | 1348 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 4012 | 0.020 |
Why?
|
| Income | 1 | 2017 | 1876 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 1577 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 1430 | 0.020 |
Why?
|
| Physical Examination | 1 | 2014 | 1244 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2019 | 2689 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 2249 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 753 | 0.020 |
Why?
|
| Granuloma, Pyogenic | 1 | 2008 | 47 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2220 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 13249 | 0.020 |
Why?
|
| Palate | 1 | 2008 | 124 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2008 | 252 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 247 | 0.020 |
Why?
|
| Americas | 1 | 2007 | 111 | 0.020 |
Why?
|
| Cattle | 1 | 2013 | 3847 | 0.020 |
Why?
|
| Root Canal Therapy | 1 | 2008 | 66 | 0.020 |
Why?
|
| Drug Costs | 1 | 2016 | 1184 | 0.020 |
Why?
|
| Cicatrix | 1 | 2013 | 781 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18134 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2012 | 1684 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 2945 | 0.020 |
Why?
|
| Trigeminal Neuralgia | 1 | 2008 | 106 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2012 | 665 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 782 | 0.020 |
Why?
|
| Malnutrition | 1 | 2014 | 638 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2014 | 2207 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 2007 | 375 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2017 | 1809 | 0.020 |
Why?
|
| Research Design | 1 | 2023 | 6181 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2014 | 1032 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 968 | 0.020 |
Why?
|
| Arteries | 1 | 2012 | 1126 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 2633 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7803 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2932 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 18968 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 2202 | 0.020 |
Why?
|
| Minerals | 1 | 2007 | 283 | 0.020 |
Why?
|
| Mental Health | 1 | 2020 | 3206 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2012 | 1478 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 787 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 6017 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2009 | 600 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 2731 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4920 | 0.020 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2008 | 220 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2008 | 615 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2008 | 1975 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2013 | 2837 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2008 | 580 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8498 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2776 | 0.010 |
Why?
|
| Calcinosis | 1 | 2012 | 1478 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7016 | 0.010 |
Why?
|
| Tissue Engineering | 1 | 2013 | 1867 | 0.010 |
Why?
|
| Macrophages | 1 | 2018 | 5745 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4374 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2008 | 642 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1899 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10829 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3665 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14396 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2008 | 1271 | 0.010 |
Why?
|
| Disease Management | 1 | 2012 | 2508 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2008 | 1505 | 0.010 |
Why?
|
| Smoking | 1 | 2017 | 9070 | 0.010 |
Why?
|
| Epidermis | 1 | 2003 | 529 | 0.010 |
Why?
|
| Musculoskeletal Diseases | 1 | 2006 | 594 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 943 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2010 | 1718 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 2007 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2006 | 1266 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2012 | 24086 | 0.010 |
Why?
|
| Neoplasms, Second Primary | 1 | 2007 | 1060 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2005 | 1395 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2007 | 22041 | 0.010 |
Why?
|
| Length of Stay | 1 | 2012 | 6472 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17766 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22025 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2006 | 1089 | 0.010 |
Why?
|
| Obesity | 1 | 2019 | 12915 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4358 | 0.010 |
Why?
|
| Mice | 2 | 2017 | 81216 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23363 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 4739 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 5206 | 0.010 |
Why?
|